{"eventGroups":[{"deathsNumAffected":26,"deathsNumAtRisk":30,"description":"During the treatment phase of the study, eligible patients will receive assigned treatments in 3 week cycles until progression.\n\nCDX-3379 and cetuximab: Dose: 12 mg/kg CDX-3379 once every 3 weeks in combination with 400 mg/m2 cetuximab on the first day followed by weekly doses of 250 mg/m2 cetuximab.","id":"EG000","otherNumAffected":30,"otherNumAtRisk":30,"seriousNumAffected":13,"seriousNumAtRisk":30,"title":"CDX-3379 and Cetuximab"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":30}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":30}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":30}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":30}],"term":"Dysphagia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":30}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Flatulence"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":30}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":30}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":30}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":30}],"term":"Hypercalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":30}],"term":"Hypoalbuminaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":30}],"term":"Hypophosphataemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":30}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":30}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Malnutrition"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Hypoglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Hypernatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":30}],"term":"Dermatitis acneiform"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":30}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Skin induration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Palmar-plantar erythrodysaesthesia syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Pruritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Erythema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Urticaria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":30}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":30}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Thirst"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Face oedema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Catheter site pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":30}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":30}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Blood lactate dehydrogenase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Blood alkaline phosphatase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"White blood cell count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Amylase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Lipase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Electrocardiogram QT prolonged"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"International normalised ratio increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Productive cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":30}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Oropharyngeal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":30}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Presyncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":30}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Dysgeusia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Paronychia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Skin infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Fungal skin infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Radiation skin injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Skin laceration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":30}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Blepharitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Vision blurred"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":30}],"term":"Proteinuria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":30}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Confusional state"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Agitation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Tumour pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Fall"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Lung abscess"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Small intestinal haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Mucosal inflammation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Non-cardiac chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Femoral neck fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Gastrostomy tube site complication"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Tracheal obstruction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Respiratory arrest"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Leukocytosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Electrocardiogram QT prolonged"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Failure to thrive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Tumour haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (23.1)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":30}],"term":"Encephalopathy"}],"timeFrame":"Adverse events were collected from initiation of treatment until 30 days after discontinuing treatment or initiation of new anti-cancer medication."}